CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 536 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 413 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 466 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 400 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 461 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 422 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 504 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 426 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 424 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 414 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 414 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 403 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 425 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 442 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 415 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 402 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 457 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 402 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 380 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 399 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 436 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 433 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 468 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 399 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy